Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seyed Moayed Alavian

Showing results (281-290 of 327) with videos related to

Pageof 33
Sort By:
Trials|June 9, 2017
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trialMilad Daneshi-Maskooni, Seyed Ali Keshavarz, Siavash Mansouri, et al.
Hepatitis Monthly|January 27, 2017
Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors among Prisoners in Razavi Khorasan Province, Iran, in 2008Mohammad Khajedaluee, Ali Babaei, Rosita Vakili, et al.
Hepatitis Monthly|March 5, 2015
Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinomaKavous Firouznia, Hossein Ghanaati, Seyed Moayed Alavian, et al.
Asian Pacific Journal of Tropical Biomedicine|April 10, 2013
Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver diseaseMohammad Ebrahim Ghamar-Chehreh, Mohsen Amini, Hossein Khedmat, et al.
Journal of Medical Virology|January 19, 2006
Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary reportSamad Amini-Bavil-Olyaee, Seyed-Moayed Alavian, Ahmad Adeli, et al.
World Journal of Gastroenterology|September 23, 2008
Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patientsGolnaz Bahramali, Majid Sadeghizadeh, Samad Amini-Bavil-Olyaee, et al.
Journal of Medical Virology|February 18, 2014
Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1Mahmoud Reza Pourkarim, Valentijn Vergote, Samad Amini-Bavil-Olyaee, et al.
Hepatitis Monthly|April 16, 2013
Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral StrainsKatayoun Samimi-Rad, Freshteh Asgari, Mohsen Nasiritoosi, et al.
Hepatitis Monthly|May 3, 2012
Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in qom province, center of iranMohammad-Reza Ghadir, Mojtaba Belbasi, Akram Heidari, et al.
Hepatitis Monthly|April 18, 2012
Distribution and risk factors of hepatitis B virus infection in the general population of Central IranMohammad Reza Ghadir, Mojtaba Belbasi, Akram Heidari, et al.
Pageof 33

Showing results (281-290 of 327) with videos related to

Sort By:
Pageof 33
Trials|June 9, 2017
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trialMilad Daneshi-Maskooni, Seyed Ali Keshavarz, Siavash Mansouri, et al.
Hepatitis Monthly|January 27, 2017
Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors among Prisoners in Razavi Khorasan Province, Iran, in 2008Mohammad Khajedaluee, Ali Babaei, Rosita Vakili, et al.
Hepatitis Monthly|March 5, 2015
Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinomaKavous Firouznia, Hossein Ghanaati, Seyed Moayed Alavian, et al.
Asian Pacific Journal of Tropical Biomedicine|April 10, 2013
Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver diseaseMohammad Ebrahim Ghamar-Chehreh, Mohsen Amini, Hossein Khedmat, et al.
Journal of Medical Virology|January 19, 2006
Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary reportSamad Amini-Bavil-Olyaee, Seyed-Moayed Alavian, Ahmad Adeli, et al.
World Journal of Gastroenterology|September 23, 2008
Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patientsGolnaz Bahramali, Majid Sadeghizadeh, Samad Amini-Bavil-Olyaee, et al.
Journal of Medical Virology|February 18, 2014
Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1Mahmoud Reza Pourkarim, Valentijn Vergote, Samad Amini-Bavil-Olyaee, et al.
Hepatitis Monthly|April 16, 2013
Patient-to-Patient Transmission of Hepatitis C at Iranian Thalassemia Centers Shown by Genetic Characterization of Viral StrainsKatayoun Samimi-Rad, Freshteh Asgari, Mohsen Nasiritoosi, et al.
Hepatitis Monthly|May 3, 2012
Prevalence of hepatitis d virus infection among hepatitis B virus infected patients in qom province, center of iranMohammad-Reza Ghadir, Mojtaba Belbasi, Akram Heidari, et al.
Hepatitis Monthly|April 18, 2012
Distribution and risk factors of hepatitis B virus infection in the general population of Central IranMohammad Reza Ghadir, Mojtaba Belbasi, Akram Heidari, et al.
Pageof 33